Wednesday, 12 July 2017

AbbVie: A “Young” Pharma Exposure?

Your daily guide to the latest dividend stock news...

Dividend.com
Trouble viewing this?
View Email as Webpage

The Dividend.com Daily Dispatch

imp?s=148095&sz=1x1&li=5465108463&e=startupbusiness84.dividend@blogger.com&p=d4e293f7a9 imp?s=148096&sz=1x1&li=5465108463&e=startupbusiness84.dividend@blogger.com&p=d4e293f7a9
imp?s=148389&sz=1x1&li=5465108463&e=startupbusiness84.dividend@blogger.com&p=d4e293f7a9 imp?s=148390&sz=1x1&li=5465108463&e=startupbusiness84.dividend@blogger.com&p=d4e293f7a9

Today's Top Stories on Dividend.com

AbbVie: A “Young” Pharma Exposure?

MV Oil Trust Sees a 10% Decrease in Dividend

What Creates More Value for Investors: Dividend Payout or Share Repurchases?

So What’s up With the Dollar?

Office REITs, Better Than Expected

Most Popular Articles on Dividend.com

d2ed2d69-7bb6-4d4d-bcf3-2468824474c9.jpg

What Amazon's Acquisition of Whole Foods Means for Other Grocery Store Chains

32082a2f-ff29-48d1-931f-d14d6dddafe4.jpg

Trending: Bank of America Gets Boost From Fed and Warren Buffett

be182aca-eebe-4d1b-aec5-e54eba8c2f53.jpg

Does Chevron Offer a Good Energy Exposure to Passive Investors?

1fe3acc9-0277-4437-a72f-17958529343c.jpg

Are the Telecoms' Plans Stalling?

ff936595-0a0e-428f-8cb0-c051301e6a49.jpg

General Electric: Should Dividend Investors Focus on the Industrial Behemoth?

imp?s=148110&sz=1x1&li=5465108463&e=startupbusiness84.dividend@blogger.com&p=d4e293f7a9 imp?s=148111&sz=1x1&li=5465108463&e=startupbusiness84.dividend@blogger.com&p=d4e293f7a9

Thank You for Subscribing!

We hope you've enjoyed this issue of the Dividend.com Daily Dispatch. Make sure you also Upgrade for a Full Year of Dividend.com Premium and get access to our Best Dividend Stocks list. We know it will be profitable for you.

Best Regards,

Dividend.com

Our mailing address is:
Dividend.com PO Box 3394 Chicago, IL 60654 USA

Update Subscription Options | Unsubscribe From This List | Forward to a Friend

©2017 Dividend.com. All rights reserved. You are receiving this mailing because you opted-in at our website, Dividend.com, which is in full compliance of the CAN-SPAM Act of 2008.

No comments:

Post a Comment